The global venous stents market held a valuation of US$ 921.4 Million in 2022, and it is anticipated to expand at a CAGR of 8.4% over the forecasted years. According to a recent study by Future Market Insights, nitinol material is leading the market with a share of about 89.5% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 921.4 Million |
| Market Value 2033 | US$ 2.2 Billion |
| CAGR 2023 to 2033 | 8.4% |
| Market Share of Top 5 Countries | 52.6% |
| Key Market Players | Becton, Dickinson and Company, Cook Group Inc, Boston Scientific Corporation, Medtronic, Koninklijke Philips N.V. (Vesper Medical Inc.), Optimed Medizinische Instrumente GmbH, plus medica GmbH & Co. KG, Abbott Laboratories, Inc. |
A venous stent is a metal mesh tube that is placed inside a blocked or narrowed vein to keep it open. It acts as a scaffold to prevent the vein from collapsing and to allow blood to flow through it. Venous stenting is a minimally invasive procedure in which a fine angioplasty catheter is inserted into the affected vein. Using sophisticated imaging technology like venous ultrasound, a physician will carefully guide the angioplasty catheter to the vein's outer limits.
Venous stents are usually placed in larger, central veins such as the legs, chest, and abdomen. Stents are also used in arteries to keep them open after plaque has been removed. Venous stenting is also helpful in reduction of chronic pain, swelling, or helpful in venous ulcer healing in serious cases of existing post-thrombotic syndrome (PTS) after past deep vein thrombosis (DVT).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the venous stents are anticipated to rise at a CAGR of 8.4% between 2023 and 2033, owing to prevalence of venous diseases, adoption of minimally invasive procedures, growing ageing population, and increasing awareness about venous stents usage.
The global market holds around 8.5% share of the overall global stents market with a value of around US$ 10.8 Billion, in 2022.
The market for venous stents is increasing due to the rising prevalence of various diseases related to the venous, such as chronic venous insufficiency, deep vein thrombosis, phlebitis, varicose and spider veins, and venous stenosis. Such aforementioned disorders require venous stents for treatment purposes, and thus, the rising prevalence of venous disorders among people is driving the market.
Similarly, rising key player’s product development strategies like flexible venous stents with high radial strength are also expanding the market growth. Significant advancement has been made in the design and development of venous stents, including innovations in stent materials, design, and delivery systems. This has resulted in the development of more effective and safer stents, which will boost the demand.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 2.2 Billion during the year 2033.
Global cases of chronic cardiovascular diseases are increasing, owing to the world's growing senior population, as older people are more prone to heart-related problems.
Obesity is also a substantial global risk factor for a number of heart ailments. The excessive or incorrect deposition of fat within the arterial wall brought on by obesity can lead to coronary heart disease and other health issues. As a result, the increased obesity rate may demand several venous surgeries which indirectly aid the market growth.
The significant growth in patient base which is raising the demand for vein stent surgery is also aiding the market growth.
Principal Consultant
The restraints of the venous stents market include the high cost of venous stent procedures, lack of skilled professionals, and the risk of complications associated with venous stent implantation. The high cost of venous stent procedures is a major restraint for the growth of the venous stent market, as it limits the adoption of these procedures in developing countries. The lack of skilled professionals is also a challenge for the growth of the venous stent market, as it limits the availability of these procedures in certain regions. The risk of complications associated with venous stent implantation, such as stent migration, stent fracture, and stent thrombosis, is also a restraint for the growth of the venous stent market. The venous stent market is highly competitive, with many players operating in the development, manufacturing, and commercialization of venous stents.
The recall of numerous venous devices from the market is another factor hindering the market growth. Recently, recalls of many product was motivated by recent documentation of unanticipated unfavorable patient effects.
The USA led the global market with value share of around 32.8% in 2022 due to rising prevalence of deep vein thrombosis.
Therefore, the demand for venous stents is increasing as a result of the rising number of DVT procedures performed nationwide.
The growing healthcare expenditure in theUSA is driving demand for venous stents as more patients seek treatment for venous diseases.
Germany held market share of around 4.4% in the global market 2022 and it is expected to expand further due to high prevalence of venous diseases.
The venous stents market in Germany is primarily driven by the increasing incidence of venous diseases and disorders. These conditions often require medical intervention, including the use of venous stents, to prevent serious complications such as pulmonary embolism or venous ulcers.
China holds a market share of 6.3% in 2022 in the global market. Increased interventional cardiology and peripheral vascular operations, as well as rising acceptance of technology developments in an effort to minimize treatment duration for high-risk patients, are the primary growth factors for this market.
Chinese regulatory approvals also confirm the quality and smooth market penetration for stents. For example, National Medical Products Administration (NMPA) regulatory services include strategy, registration, type testing, product technical requirement, and check clinical evaluation report.
India held a market share of around 3.6% in the global market 2022. The venous stents market in India is expected to grow significantly in the coming years, driven by the increasing availability of venous stents from global manufacturers. Many international companies are expanding their presence in India, either through partnerships or acquisitions of local companies, to tap into the growing demand for medical devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Nitinol material is holding the market share of 89.5% in the global market 2022 because of its benefits over other materials and availability of reimbursement.
Nitinol stents are a type of self-expanding stent made from a nickel-titanium alloy that can withstand the high pressures and forces in the veins. The use of Nitinol stents has become increasingly popular in the treatment of venous diseases due to their flexibility, durability, and ability to maintain the shape of the vein after implantation. Such advantages of the product in surgical procedures are expected to drive the adoption of Nitinol stents.
Chronic Deep Vein Thrombosis (DVT) has a market share of 41.6% in the global market 2022. The prevalence of chronic DVT is increasing due to factors such as aging, obesity, sedentary lifestyles, and an increase in the number of patients undergoing surgery or cancer treatment.
Open cell stent design has a market share of 88.1% in the global market 2022. In recent years, stents have been used more frequently in the treatment of venous disorders. Open-cell stents are made up of a mesh-like structure that allows for greater flexibility and conformability to the shape of the vein. This type of stent design has larger and more widely spaced struts compared to closed-cell stents, which can improve blood flow and reduce the risk of stent migration or fracture.
One of the advantages of open-cell stent design is that it allows for better coverage of longer lesions or areas of the vein with irregular shapes. Open-cell stents can also be compressed to a smaller profile for easier delivery through narrow or tortuous vessels.
Introducer size (F) 9 has a market share of 45.4% in the global market 2022. Introducer size 9 is an important in the venous stents market. An introducer is a device that is used to insert a stent into a blood vessel. The size of the introducer is an important consideration in venous stenting procedures, as it can impact the safety and efficacy of the procedure.
Introducer size 9 refers to an introducer with an outer diameter of 9 French (3 millimeters), which is a common size used in venous stenting procedures. Its advantage is like introducer size 9 is large enough to accommodate larger stents, which can be necessary in cases where the stenosis (narrowing) in the vein is severe.
Hospitals held a market share of 34.9% in the global market 2022. Hospitals are important end users for venous stents procedures because of availability of skilled healthcare professionals, and easy adoption of advanced technology in the hospital.
Rising incidence of chronic diseases being a major factor driving this growth. While there are no specific search results for hospital trends and drivers in the venous stents market, it can be inferred that the increasing prevalence of chronic diseases and the aging population are likely to drive demand for venous stents in hospitals. The development of new and innovative venous stents is also expected to further drive market growth.
The key players in the market are actively working to improve their positions through product approvals, partnerships, acquisitions, launches, collaborations, and agreements with both existing and up-and-coming market participants. A manufacturer's chances of capturing a sizable market share significantly increases by acquisitions and partnerships.
A few examples of strategies acquired by the key players
Similarly, recent developments related to companies manufacturing venous stents have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Historical Data Available for | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the United kingdom, Germany, Italy, Russia, Spain, France, Benelux, Nordics, Poland, Hungary, Romania, Czech Republic, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia & New Zealand, Kingdom of Saudi Arabia, Northern Africa, Türkiye, GCC Countries and South Africa |
| Key Market Segments Covered | Material, Indication, Stent Design, Introducer Size, End User, and Region |
| Key Companies Profiled | Becton, Dickinson and Company; Cook Group Inc.; Boston Scientific Corporation; Medtronic; Koninklijke Philips N.V. (Vesper Medical Inc.); Optimed Medizinische Instrumente GmbH; plus medica GmbH & Co. KG; Abbott Laboratories, Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is worth US$ 921.4 Million for 2022, and is set to expand 2.4X over the next ten years.
The global market estimates for 2023 is around US$ 990.5 Million.
The global market is set to reach US$ 2.2 Billion by end of 2033.
The global market exhibited a value CAGR of 6.9% in the last 4 years.
The global market is set to expand at a CAGR of 8.4% between 2023 and 2033.
Nitinol material held a significant share of 89.5% in 2022 globally.
Hybrid stent design will expanded rapidly with at a CAGR of 11.3% between 2023 and 2033.
Rising prevalence of venous diseases, adoption of minimally invasive procedures, growing ageing population, and increasing awareness about venous stents usage are the key trends of the market.
North American region dominated the global market with USA contributing around US$ 301.9 Million in 2022
Hospitals held a market share of around 34.9% in the global market 2022.
1. Executive Summary | Venous Stents Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Product USP/Features Analysis 4.3. Regulatory Landscape, By Key Countries 4.4. Reimbursement Scenario 4.5. Recent Product Approvals/Launches 4.6. Supply Chain Analysis 4.7. Porter’s Analysis 4.8. Technological Assessment 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.1.3. Global Stents Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. New Product Launches and Approvals 5.2.3. Epidemiology of Venous Diseases 5.2.4. Global Epidemiology of Venous Thromboembolism 5.2.5. R&D Expenditure by Key Players 5.2.6. Historic and Current Revenue of key players 5.2.7. Rising Consumer Awareness of the Product 5.2.8. Rising Adoption of Device Technological development 5.2.9. Strategic Developments by Key Players 5.2.10. Increase Adoption of Different for Venous Thromboembolism 5.2.11. Strategic Collaborations among Players 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity 6. COVID-19 Crisis – Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Material 6.1.2. Revenue By Indication 6.1.3. Revenue By Stent Design 6.1.4. Revenue by Introducer Size 6.1.5. Revenue By End User 6.1.6. Revenue By Region 6.2. 2022 Market Scenario 7. Global Market Demand (Volume in Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Material Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level 8.2.2. Distributor Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value US$ Million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Material, 2018 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Material, 2023 to 2033 10.3.1. Nitinol 10.3.2. Elgiloy 10.4. Market Attractiveness Analysis By Material 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) By Indication, 2018 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 11.3.1. Chronic Deep Vein Thrombosis 11.3.2. Post-Thrombotic Syndrome (PTS) 11.3.3. May-Thurner’s Syndrome (MTS) 11.3.4. Pelvic Congestion Syndrome (PCS) 11.3.5. Others 11.4. Market Attractiveness Analysis By Indication 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stent Design 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) By Stent Design, 2018 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Stent Design, 2023 to 2033 12.3.1. Braided 12.3.2. Open Cell 12.3.3. Closed Cell 12.3.4. Hybrid 12.4. Market Attractiveness Analysis By Stent Design 13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Introducer Size 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) By Introducer Size, 2018 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Introducer Size, 2023 to 2033 13.3.1. Size - 6 13.3.2. Size - 7 13.3.3. Size - 8 13.3.4. Size - 9 13.3.5. Size - 10 13.4. Market Attractiveness Analysis By Introducer Size 14. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) By End User, 2018 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 14.3.1. Hospital 14.3.2. Ambulatory Surgery Centers 14.3.3. Specialty Clinics 14.3.4. Cardiac Catheterization Labs 14.4. Market Attractiveness Analysis By End User 15. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2018 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033 15.3.1. North America 15.3.2. Latin America 15.3.3. East Asia 15.3.4. South Asia & Pacific 15.3.5. Western Europe 15.3.6. Eastern Europe 15.3.7. Central Asia 15.3.8. Russia & Belarus 15.3.9. Balkan & Baltic Countries 15.3.10. Middle East and Africa 15.4. Market Attractiveness Analysis By Region 16. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. USA 16.3.1.2. Canada 16.3.2. By Material 16.3.3. By Indication 16.3.4. By Stent Design 16.3.5. By Introducer Size 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Material 16.4.3. By Indication 16.4.4. By Stent Design 16.4.5. By Introducer Size 16.4.6. By End User 16.5. Market Trends 16.6. PESTLE Analysis 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country Level Analysis & Forecast 16.9.1. USA Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Material 16.9.1.2.2. By Indication 16.9.1.2.3. By Stent Design 16.9.1.2.4. By Introducer Size 16.9.1.2.5. By End User 16.9.2. Canada Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Material 16.9.2.2.2. By Indication 16.9.2.2.3. By Stent Design 16.9.2.2.4. By Introducer Size 16.9.2.2.5. By End User 17. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Brazil 17.3.1.2. Mexico 17.3.1.3. Argentina 17.3.1.4. Rest of LATAM 17.3.2. By Material 17.3.3. By Indication 17.3.4. By Stent Design 17.3.5. By Introducer Size 17.3.6. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Material 17.4.3. By Indication 17.4.4. By Stent Design 17.4.5. By Introducer Size 17.4.6. By End User 17.5. Market Trends 17.6. PESTLE Analysis 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country Level Analysis & Forecast 17.9.1. Brazil Market Analysis 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Material 17.9.1.2.2. By Indication 17.9.1.2.3. By Stent Design 17.9.1.2.4. By Introducer Size 17.9.1.2.5. By End User 17.9.2. Mexico Market Analysis 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Material 17.9.2.2.2. By Indication 17.9.2.2.3. By Stent Design 17.9.2.2.4. By Introducer Size 17.9.2.2.5. By End User 17.9.3. Argentina Market Analysis 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Material 17.9.3.2.2. By Indication 17.9.3.2.3. By Stent Design 17.9.3.2.4. By Introducer Size 17.9.3.2.5. By End User 18. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Material 18.3.3. By Indication 18.3.4. By Stent Design 18.3.5. By Introducer Size 18.3.6. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Material 18.4.3. By Indication 18.4.4. By Stent Design 18.4.5. By Introducer Size 18.4.6. By End User 18.5. Market Trends 18.6. PESTLE Analysis 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 18.9. Country Level Analysis & Forecast 18.9.1. China Market Analysis 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Material 18.9.1.2.2. By Indication 18.9.1.2.3. By Stent Design 18.9.1.2.4. By Introducer Size 18.9.1.2.5. By End User 18.9.2. Japan Market Analysis 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Material 18.9.2.2.2. By Indication 18.9.2.2.3. By Stent Design 18.9.2.2.4. By Introducer Size 18.9.2.2.5. By End User 18.9.3. South Korea Market Analysis 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Material 18.9.3.2.2. By Indication 18.9.3.2.3. By Stent Design 18.9.3.2.4. By Introducer Size 18.9.3.2.5. By End User 19. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Indonesia 19.3.1.3. Thailand 19.3.1.4. Philippines 19.3.1.5. Malaysia 19.3.1.6. Vietnam 19.3.1.7. Rest of ASEAN 19.3.1.8. Australia & New Zeland 19.3.2. By Material 19.3.3. By Indication 19.3.4. By Stent Design 19.3.5. By Introducer Size 19.3.6. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Material 19.4.3. By Indication 19.4.4. By Stent Design 19.4.5. By Introducer Size 19.4.6. By End User 19.5. Market Trends 19.6. PESTLE Analysis 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 19.9. Country Level Analysis & Forecast 19.9.1. India Market Analysis 19.9.1.1. Introduction 19.9.1.2. Market Analysis and Forecast by Market Taxonomy 19.9.1.2.1. By Material 19.9.1.2.2. By Indication 19.9.1.2.3. By Stent Design 19.9.1.2.4. By Introducer Size 19.9.1.2.5. By End User 19.9.2. Indonesia Market Analysis 19.9.2.1. Introduction 19.9.2.2. Market Analysis and Forecast by Market Taxonomy 19.9.2.2.1. By Material 19.9.2.2.2. By Indication 19.9.2.2.3. By Stent Design 19.9.2.2.4. By Introducer Size 19.9.2.2.5. By End User 19.9.3. Thailand Market Analysis 19.9.3.1. Introduction 19.9.3.2. Market Analysis and Forecast by Market Taxonomy 19.9.3.2.1. By Material 19.9.3.2.2. By Indication 19.9.3.2.3. By Stent Design 19.9.3.2.4. By Introducer Size 19.9.3.2.5. By End User 19.9.4. Philippines Market Analysis 19.9.4.1. Introduction 19.9.4.2. Market Analysis and Forecast by Market Taxonomy 19.9.4.2.1. By Material 19.9.4.2.2. By Indication 19.9.4.2.3. By Stent Design 19.9.4.2.4. By Introducer Size 19.9.4.2.5. By End User 19.9.5. Malaysia Market Analysis 19.9.5.1. Introduction 19.9.5.2. Market Analysis and Forecast by Market Taxonomy 19.9.5.2.1. By Material 19.9.5.2.2. By Indication 19.9.5.2.3. By Stent Design 19.9.5.2.4. By Introducer Size 19.9.5.2.5. By End User 19.9.6. Vietnam Market Analysis 19.9.6.1. Introduction 19.9.6.2. Market Analysis and Forecast by Market Taxonomy 19.9.6.2.1. By Material 19.9.6.2.2. By Indication 19.9.6.2.3. By Stent Design 19.9.6.2.4. By Introducer Size 19.9.6.2.5. By End User 19.9.7. Australia & New Zealand Market Analysis 19.9.7.1. Introduction 19.9.7.2. Market Analysis and Forecast by Market Taxonomy 19.9.7.2.1. By Material 19.9.7.2.2. By Indication 19.9.7.2.3. By Stent Design 19.9.7.2.4. By Introducer Size 19.9.7.2.5. By End User 20. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. Germany 20.3.1.2. France 20.3.1.3. Spain 20.3.1.4. Italy 20.3.1.5. BENELUX 20.3.1.6. Nordics 20.3.1.7. United Kingdom 20.3.2. By Material 20.3.3. By Indication 20.3.4. By Stent Design 20.3.5. By Introducer Size 20.3.6. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Material 20.4.3. By Indication 20.4.4. By Stent Design 20.4.5. By Introducer Size 20.4.6. By End User 20.5. Market Trends 20.6. PESTLE Analysis 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country Level Analysis & Forecast 20.9.1. Germany Market Analysis 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Material 20.9.1.2.2. By Indication 20.9.1.2.3. By Stent Design 20.9.1.2.4. By Introducer Size 20.9.1.2.5. By End User 20.9.2. France Market Analysis 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Material 20.9.2.2.2. By Indication 20.9.2.2.3. By Stent Design 20.9.2.2.4. By Introducer Size 20.9.2.2.5. By End User 20.9.3. Spain Market Analysis 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Material 20.9.3.2.2. By Indication 20.9.3.2.3. By Stent Design 20.9.3.2.4. By Introducer Size 20.9.3.2.5. By End User 20.9.4. Italy Market Analysis 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Material 20.9.4.2.2. By Indication 20.9.4.2.3. By Stent Design 20.9.4.2.4. By Introducer Size 20.9.4.2.5. By End User 20.9.5. BENELUX Market Analysis 20.9.5.1. Introduction 20.9.5.2. Market Analysis and Forecast by Market Taxonomy 20.9.5.2.1. By States 20.9.5.2.1.1. Belgium 20.9.5.2.1.2. Netherlands 20.9.5.2.1.3. Luxembourg 20.9.5.2.2. By Material 20.9.5.2.3. By Indication 20.9.5.2.4. By Stent Design 20.9.5.2.5. By Introducer Size 20.9.5.2.6. By End User 20.9.6. Nordic Countries Market Analysis 20.9.6.1. Introduction 20.9.6.2. Market Analysis and Forecast by Market Taxonomy 20.9.6.2.1. By States 20.9.6.2.1.1. Denmark 20.9.6.2.1.2. Norway 20.9.6.2.1.3. Sweden 20.9.6.2.1.4. Finland 20.9.6.2.1.5. Iceland 20.9.6.2.1.6. Greenland 20.9.6.2.2. By Material 20.9.6.2.3. By Indication 20.9.6.2.4. By Stent Design 20.9.6.2.5. By Introducer Size 20.9.6.2.6. By End User 20.9.7. United Kingdom Market Analysis 20.9.7.1. Introduction 20.9.7.2. Market Analysis and Forecast by Market Taxonomy 20.9.7.2.1. By Material 20.9.7.2.2. By Indication 20.9.7.2.3. By Stent Design 20.9.7.2.4. By Introducer Size 20.9.7.2.5. By End User 21. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 21.1. Introduction 21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022 21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 21.3.1. By Country 21.3.1.1. Poland 21.3.1.2. Hungary 21.3.1.3. Romania 21.3.1.4. Czech Republic 21.3.1.5. Others 21.3.2. By Material 21.3.3. By Indication 21.3.4. By Stent Design 21.3.5. By Introducer Size 21.3.6. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Material 21.4.3. By Indication 21.4.4. By Stent Design 21.4.5. By Introducer Size 21.4.6. By End User 21.5. Market Trends 21.6. PESTLE Analysis 21.7. Key Market Participants - Intensity Mapping 21.8. Drivers and Restraints - Impact Analysis 21.9. Country Level Analysis & Forecast 21.9.1. Poland Market Analysis 21.9.1.1. Introduction 21.9.1.2. Market Analysis and Forecast by Market Taxonomy 21.9.1.2.1. By Material 21.9.1.2.2. By Indication 21.9.1.2.3. By Stent Design 21.9.1.2.4. By Introducer Size 21.9.1.2.5. By End User 21.9.2. Hungary Market Analysis 21.9.2.1. Introduction 21.9.2.2. Market Analysis and Forecast by Market Taxonomy 21.9.2.2.1. By Material 21.9.2.2.2. By Indication 21.9.2.2.3. By Stent Design 21.9.2.2.4. By Introducer Size 21.9.2.2.5. By End User 21.9.3. Romania Market Analysis 21.9.3.1. Introduction 21.9.3.2. Market Analysis and Forecast by Market Taxonomy 21.9.3.2.1. By Material 21.9.3.2.2. By Indication 21.9.3.2.3. By Stent Design 21.9.3.2.4. By Introducer Size 21.9.3.2.5. By End User 21.9.4. Czech Republic Market Analysis 21.9.4.1. Introduction 21.9.4.2. Market Analysis and Forecast by Market Taxonomy 21.9.4.2.1. By Material 21.9.4.2.2. By Indication 21.9.4.2.3. By Stent Design 21.9.4.2.4. By Introducer Size 21.9.4.2.5. By End User 22. Central Asia Market 2018 to 2022 and Forecast 2023 to 2033 22.1. Introduction 22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022 22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 22.3.1. By Material 22.3.2. By Indication 22.3.3. By Stent Design 22.3.4. By Introducer Size 22.3.5. By End User 22.4. Market Attractiveness Analysis 22.4.1. By Material 22.4.2. By Indication 22.4.3. By Stent Design 22.4.4. By Introducer Size 22.4.5. By End User 22.5. Market Trends 22.6. PESTLE Analysis 22.7. Key Market Participants - Intensity Mapping 22.8. Drivers and Restraints - Impact Analysis 23. Russia & Belarus Market 2018 to 2022 and Forecast 2023 to 2033 23.1. Introduction 23.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis By Market Taxonomy, 2018 to 2022 23.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 23.3.1. By Material 23.3.2. By Indication 23.3.3. By Stent Design 23.3.4. By Introducer Size 23.3.5. By End User 23.4. Market Attractiveness Analysis 23.4.1. By Material 23.4.2. By Indication 23.4.3. By Stent Design 23.4.4. By Introducer Size 23.4.5. By End User 23.5. Market Trends 23.6. PESTLE Analysis 23.7. Key Market Participants - Intensity Mapping 23.8. Drivers and Restraints - Impact Analysis 24. Balkan & Baltic Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 24.1. Introduction 24.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022 24.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 24.3.1. By Material 24.3.2. By Indication 24.3.3. By Stent Design 24.3.4. By Introducer Size 24.3.5. By End User 24.4. Market Attractiveness Analysis 24.4.1. By Material 24.4.2. By Indication 24.4.3. By Stent Design 24.4.4. By Introducer Size 24.4.5. By End User 24.5. Market Trends 24.6. PESTLE Analysis 24.7. Key Market Participants - Intensity Mapping 24.8. Drivers and Restraints - Impact Analysis 25. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 25.1. Introduction 25.2. Historical Market Size (US$ Million) and Volume (Units) Analysis Trend Analysis by Market Taxonomy, 2018 to 2022 25.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 25.3.1. By Country 25.3.1.1. GCC Countries 25.3.1.2. Kingdom of Saudi Arabia 25.3.1.3. Türkiye 25.3.1.4. Northern Africa 25.3.1.5. South Africa 25.3.1.6. Israel 25.3.2. By Material 25.3.3. By Indication 25.3.4. By Stent Design 25.3.5. By Introducer Size 25.3.6. By End User 25.4. Market Attractiveness Analysis 25.4.1. By Country 25.4.2. By Material 25.4.3. By Indication 25.4.4. By Stent Design 25.4.5. By Introducer Size 25.4.6. By End User 25.5. Market Trends 25.6. PESTLE Analysis 25.7. Key Market Participants - Intensity Mapping 25.8. Drivers and Restraints - Impact Analysis 25.9. Country Level Analysis & Forecast 25.9.1. GCC Countries Market Analysis 25.9.1.1. Introduction 25.9.1.2. Market Analysis and Forecast by Market Taxonomy 25.9.1.2.1. By Material 25.9.1.2.2. By Indication 25.9.1.2.3. By Stent Design 25.9.1.2.4. By Introducer Size 25.9.1.2.5. By End User 25.9.2. Kingdom of Saudi Arabia Market Analysis 25.9.2.1. Introduction 25.9.2.2. Market Analysis and Forecast by Market Taxonomy 25.9.2.2.1. By Material 25.9.2.2.2. By Indication 25.9.2.2.3. By Stent Design 25.9.2.2.4. By Introducer Size 25.9.2.2.5. By End User 25.9.3. Türkiye Market Analysis 25.9.3.1. Introduction 25.9.3.2. Market Analysis and Forecast by Market Taxonomy 25.9.3.2.1. By Material 25.9.3.2.2. By Indication 25.9.3.2.3. By Stent Design 25.9.3.2.4. By Introducer Size 25.9.3.2.5. By End User 25.9.4. Northern Africa Market Analysis 25.9.4.1. Introduction 25.9.4.2. Market Analysis and Forecast by Market Taxonomy 25.9.4.2.1. By Material 25.9.4.2.2. By Indication 25.9.4.2.3. By Stent Design 25.9.4.2.4. By Introducer Size 25.9.4.2.5. By End User 25.9.5. South Africa Market Analysis 25.9.5.1. Introduction 25.9.5.2. Market Analysis and Forecast by Market Taxonomy 25.9.5.2.1. By Material 25.9.5.2.2. By Indication 25.9.5.2.3. By Stent Design 25.9.5.2.4. By Introducer Size 25.9.5.2.5. By End User 25.9.6. Israel Market Analysis 25.9.6.1. Introduction 25.9.6.2. Market Analysis and Forecast by Market Taxonomy 25.9.6.2.1. By Material 25.9.6.2.2. By Indication 25.9.6.2.3. By Stent Design 25.9.6.2.4. By Introducer Size 25.9.6.2.5. By End User 26. Market Structure Analysis 26.1. Market Analysis by Tier of Companies 26.2. Market Share Analysis of Top Players (%) 26.3. Market Presence Analysis 26.3.1. By Regional Footprint of Players 26.3.2. Product Footprint of Players 26.3.3. Channel Footprint of Players 27. Competition Analysis 27.1. Competition Dashboard 27.2. Competition Benchmarking 27.3. Competition Deep Dive 27.3.1. Becton, Dickinson and Company 27.3.1.1. Overview 27.3.1.2. Product Portfolio 27.3.1.3. Key Financials 27.3.1.4. SWOT Analysis 27.3.1.5. Key Developments 27.3.1.6. Sales Footprint 27.3.1.7. Strategy Overview 27.3.1.7.1. Marketing Strategies 27.3.1.7.2. Product Strategies 27.3.1.7.3. Channel Strategies 27.3.2. Cook Group Inc 27.3.2.1. Overview 27.3.2.2. Product Portfolio 27.3.2.3. Key Financials 27.3.2.4. SWOT Analysis 27.3.2.5. Key Developments 27.3.2.6. Sales Footprint 27.3.2.7. Strategy Overview 27.3.2.7.1. Marketing Strategies 27.3.2.7.2. Product Strategies 27.3.2.7.3. Channel Strategies 27.3.3. Boston Scientific Corporation 27.3.3.1. Overview 27.3.3.2. Product Portfolio 27.3.3.3. Key Financials 27.3.3.4. SWOT Analysis 27.3.3.5. Key Developments 27.3.3.6. Sales Footprint 27.3.3.7. Strategy Overview 27.3.3.7.1. Marketing Strategies 27.3.3.7.2. Product Strategies 27.3.3.7.3. Channel Strategies 27.3.4. Medtronic 27.3.4.1. Overview 27.3.4.2. Product Portfolio 27.3.4.3. Key Financials 27.3.4.4. SWOT Analysis 27.3.4.5. Key Developments 27.3.4.6. Sales Footprint 27.3.4.7. Strategy Overview 27.3.4.7.1. Marketing Strategies 27.3.4.7.2. Product Strategies 27.3.4.7.3. Channel Strategies 27.3.5. Koninklijke Philips N.V. (Vesper Medical Inc.) 27.3.5.1. Overview 27.3.5.2. Product Portfolio 27.3.5.3. Key Financials 27.3.5.4. SWOT Analysis 27.3.5.5. Key Developments 27.3.5.6. Sales Footprint 27.3.5.7. Strategy Overview 27.3.5.7.1. Marketing Strategies 27.3.5.7.2. Product Strategies 27.3.5.7.3. Channel Strategies 27.3.6. Optimed Medizinische Instrumente GmbH 27.3.6.1. Overview 27.3.6.2. Product Portfolio 27.3.6.3. Key Financials 27.3.6.4. SWOT Analysis 27.3.6.5. Key Developments 27.3.6.6. Sales Footprint 27.3.6.7. Strategy Overview 27.3.6.7.1. Marketing Strategies 27.3.6.7.2. Product Strategies 27.3.6.7.3. Channel Strategies 27.3.7. plus medica GmbH & Co. KG 27.3.7.1. Overview 27.3.7.2. Product Portfolio 27.3.7.3. Key Financials 27.3.7.4. SWOT Analysis 27.3.7.5. Key Developments 27.3.7.6. Sales Footprint 27.3.7.7. Strategy Overview 27.3.7.7.1. Marketing Strategies 27.3.7.7.2. Product Strategies 27.3.7.7.3. Channel Strategies 27.3.8. Abbott Laboratories, Inc. 27.3.8.1. Overview 27.3.8.2. Product Portfolio 27.3.8.3. Key Financials 27.3.8.4. SWOT Analysis 27.3.8.5. Key Developments 27.3.8.6. Sales Footprint 27.3.8.7. Strategy Overview 27.3.8.7.1. Marketing Strategies 27.3.8.7.2. Product Strategies 27.3.8.7.3. Channel Strategies 28. Assumptions and Acronyms Used 29. Research Methodolog
Explore Healthcare Insights
View Reports
Venous Stents Market
